期刊文献+

CARMA1基因在活化B细胞样亚型弥漫大B细胞淋巴瘤中的研究进展 被引量:2

Research progress of CARMA1 gene in activated B cell-like subtype of diffuse large B cell lymphoma
原文传递
导出
摘要 弥漫大B细胞淋巴瘤(DLBCL)为常见的侵袭性淋巴瘤,其中活化B细胞样(ABC)亚型DLBCL患者复发率高、生存率低,预后差.核因子(NF)-κB信号通路持续过度活化,是区分ABC亚型DLBCL与其他亚型DLBCL的显著特征之一,亦为导致ABC亚型DLBCL疾病发生的关键信号通路.近年,多项研究结果证实CARMA1通过调控NF-κB信号通路,进而在ABC亚型DLBCL疾病发生中发挥重要作用.笔者拟就CARMA1功能、基因点突变及翻译后修饰等方面对ABC亚型DLBCL疾病发生的影响进行综述. Diffuse large B cell lymphoma (DLBCL) is a common and aggressive lymphoma.Activated B cell-like (ABC) subtype of DLBCL patients are characterized by high recurrence rate,low survival rate and poor prognosis.Continued excessive activation of Nuclear factor (NF)-κB signaling pathway is the most significant feature of ABC subtype of DLBCL which differentiate it from other subtypes of DLBCL,and it is also one of the key signaling pathways which lead to ABC subtype of DLBCL.In recent years,many research results confirmed that CARMA1 plays an important role in ABC subtype of DLBCL occurrence through the regulation of NF-κB signaling pathway.The article reviews literatures on CARMA1 function,gene mutation and post translation modification impact on ABC subtype of DLBCL.
出处 《国际输血及血液学杂志》 CAS 2015年第2期157-161,共5页 International Journal of Blood Transfusion and Hematology
基金 国家自然科学基金资助项目(81400167) 江苏省自然科学基金青年基金资助项目(BK20140227)
关键词 淋巴瘤 大昏细胞 弥漫性 CARMA1蛋白 NF-ΚB Lymphoma, large B-cell, diffuses CARMA1 proteins NF-kappa B
  • 相关文献

二级参考文献162

  • 1Compagno M, Lim WK, Grunn A, et al. Mutations ofmultiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 2009; 459:717-721. 被引量:1
  • 2Montesinos-Rongen M, Schmitz R, Brunn A, et al. Mutations of CARDll but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma. Acta Neulvpatho12010; 120:529-535. 被引量:1
  • 3Lamason RL, McCully RR, Lew SM, Pomerantz JL. Oncogenic CARD 11 Mutations Induce Hyperactive Signaling by Disrupting Autoinhibition by the PKC-Responsive Inhibitory Domain. Biochemistry 2010; 49:8240-8250. 被引量:1
  • 4Hailfinger S, Lenz G, Ngo V, et al. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. ProcNatlAcadSci USA 2009; 106:19946-19951. 被引量:1
  • 5Ferch U, Kloo B, Gewies A, et al. Inhibition of MALT1 protease activity is selectively toxic for activated B celllike diffuse large B cell lymphoma cells. J Exp Med 2009; 206:2313-2320. 被引量:1
  • 6Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med2001; 194:1861-1874. 被引量:1
  • 7Lam LT, Davis RE, Pierce J, et al. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profi- ling. Clin Cancer Res 2005; 11:28-40. 被引量:1
  • 8Grabiner BC, Blonska M, Lin PC, et al. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes Dev 2007; 21:984-996. 被引量:1
  • 9Lefkowitz RJ. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmaeol Sci 2004; 25:413-422. 被引量:1
  • 10Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 2003; 3:582-591. 被引量:1

共引文献14

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部